Cell signaling news
Here we present recent news items specially selected from Nature, Nature Medicine and Nature Biotechnology.
April 2005
2005:
December |
November |
October |
September |
August |
July |
June |
May |
April |
March |
February |
January
Other years: 2002 | 2003 | 2004 | 2006 | 2007 | 2008 | 2009 | 2010
News | News in brief | News Features
News
Turkish government accused of hijacking boosted science budget
Turkey's Prime Minister recently tripled the country's main science funding body's budget to $300 million, as part of Turkey's negotiations for membership of the European Union. But it is clear that he would like more control over how the money is spent.
Nature (28 April 2005)
| Full Text |
US experts draw up guidelines for stem-cell research
Every institution working with human embryonic stem cells should create a committee to oversee the research, says the National Academy of Sciences panel, which also recommends that some experiments should be banned.
Nature (28 April 2005)
| Full Text |
Corporate culture nets big bucks for university heads
A growing tendency for US universities to embrace private-sector attitudes is undermining the system, say many of the country's professors, as many campus presidents are now paid as if they were corporate chief executives.
Nature (28 April 2005)
| Full Text |
Heightened security after flu scare sparks biosafety debate
US scientists who work with deadly strains of influenza are facing tighter restrictions on how they handle the viruses.
Nature (21 April 2005)
| Full Text |
Conclave kindles hope for bioethical reform
Questions raised by medical advances, such as human stem-cell and embryo research, and the spread of AIDS will create significant challenges for the next Pope, say religious experts.
Nature (21 April 2005)
| Full Text |
Scientists speak out in search of fame and fortune
UK scientists have been subjecting themselves to quite an ordeal in a bid to win the science-communication competition FameLab.
Nature (21 April 2005)
| Full Text |
Divergent local laws threaten to stifle Europe's stem-cell project
A high-profile European collaboration in human embryonic stem-cell research is showing signs of trouble because of the muddled legal situation surrounding stem-cell research in the European Union.
Nature (14 April 2005)
| Full Text |
Health study sets sights on a million people
Epidemiologists are meeting this week to discuss whether they can pull off the biggest health survey ever attempted — a project that would track the genes, lifestyles and health of more than a million people across Asia.
Nature (14 April 2005)
| Full Text |
War of words deepens divide over biodefence funds
Relations between disgruntled microbiologists and their paymasters at the US National Institutes of Health (NIH) are degenerating in a very public way; the issue at hand being whether the influx of cash for studies on potential bioweapons is draining vital resources from basic research.
Nature (14 April 2005)
| Full Text |
Peptide leads new class of chronic pain drugs
Two new drugs for treating severe, chronic pain, with a completely different mechanism of action — targeting N-type calcium channels — are making their market debuts in the US and Europe.
Nature Biotechnology (April 2005)
| Full Text |
Syrrx acquisition signals maturation of structure-based discovery
The application of structural biology as a starting point for drug development is now maturing as recent development in the industry suggests.
Nature Biotechnology (April 2005)
| Full Text |
Australian biotech suffers growing pains
Australia's biotech sector with too many immature companies, and not enough sophisticated investors, is struggling to achieve stability and growth.
Nature Biotechnology (April 2005)
| Full Text |
Pope praised for partial conciliation of science and religion
Catholic researchers and bioethicists have responded to the death of Pope John Paul II with tributes to his efforts to achieve reconciliation between faith and science.
Nature (07 April 2005)
| Full Text |
Professors bristle as states act to mould lecture content
University faculty members in the United States are gearing up to oppose state bills that are being put forward by conservatives in the name of academic freedom.
Nature (07 April 2005)
| Full Text |
Bitter criticism sours new diabetes research plan
Several researchers have opted out of the Juvenile Diabetes Research Foundation's (JDRF) new research program to fight juvenile diabetes, sharply criticizing the model as inappropriate for academic research.
Nature Medicine (April 2005)
| Full Text |
Therapies come closer with 'cleaner' stem cell lines
Scientists have for the first time created a line of human stem cells without using animal cells, raising hopes that researchers can grow cells that are safe for human therapy.
Nature Medicine (April 2005)
| Full Text |
Money, manpower missing from Europe's new agency
The long-awaited European Centre for Disease Prevention and Control (ECDC) will in May open its doors in Stockholm, but some experts say the center may not be up to its task of preparing Europe for major outbreaks.
Nature Medicine (April 2005)
| Full Text |
Politics roils US infectious disease center
Just as a new European agency steps into the battle against infectious diseases, its much larger US counterpart, the Center for Disease Control and Prevention (CDC), is responding to charges that it prioritizes politics over science.
Nature Medicine (April 2005)
| Full Text |
Tysabri withdrawal calls entire class into question
The future of a promising treatment for multiple sclerosis (MS) is in question after two patients taking the drug Tysabri were diagnosed with a rare neurological disorder.
Nature Medicine (April 2005)
| Full Text |
Cancer vaccine field gets shot of optimism from positive results
An experimental cancer vaccine based on dendritic cells has for the first time been shown to significantly extend the lives of men with prostate cancer.
Nature Medicine (April 2005)
| Full Text |
Aggressive HIV strain sets off dubious public health measure
In a departure from current practice, city health commissioner Thomas Frieden is urging doctors and laboratories to provide data on multidrug resistance in newly diagnosed HIV patients.
Nature Medicine (April 2005)
| Full Text |
Stray seeds had antibiotic-resistance genes
Hundreds of tonnes of genetically modified corn seeds sold to farmers by mistake over the past four years contained a gene for antibiotic resistance.
Nature (31 March 2005)
| Full Text |
Deal paves way for Congress vote on stem-cell rules
The US Congress looks set to vote on whether to loosen the restrictions that currently govern human embryonic stem-cell research.
Nature (31 March 2005)
| Full Text |
News in brief
United front boosts Asian stem-cell research
|Tough ethics rules at NIH force more staff resignations
|Europe frames plans for funding basic research
|NIH rules prompt outcry
|India boosts biotech
|UN baulks on therapeutic cloning; nations forge ahead
|US scraps study on cancer fallout from nuclear testing
|UN panel passes anti-cloning resolution
|Obesity researcher admits to faking data
|Harvard faces Summers of discontent
|Switch in Indian patent law hits generic drug industry
|Biologists join together to speak the language of RNA
News Features
Intelligent design: Who has designs on your students' minds?
The intelligent-design movement is a small but growing force on US university campuses. For some it bridges the gap between science and faith, for others it goes beyond the pale. Geoff Brumfiel meets the movement's vanguard.
Nature (28 April 2005)
| Full Text |
Image manipulation: CSI: Cell biology
Digital photography and image-manipulation software allow biologists to tweak their data as never before. But there's a fine line between acceptable enhancements and scientific misconduct. Helen Pearson investigates.
Nature (21 April 2005)
| Full Text |
Animal behaviour: When robots go wild
Surging numbers of therapeutic proteins and small molecules, rationally designed to trigger cell death, are entering the clinic against cancer. In theory, they should provide an entirely new kind of targeted therapy, but troubling questions of basic biology remain.
Nature (21 April 2005)
| Full Text |
New apoptosis drugs face critical test
Surging numbers of therapeutic proteins and small molecules, rationally designed to trigger cell death, are entering the clinic against cancer. In theory, they should provide an entirely new kind of targeted therapy, but troubling questions of basic biology remain.
Nature Biotechnology (April 2005)
| Full Text |
Tropical medicine: Melioidosis? Never heard of it...
Deadly tropical infections that kill within 48 hours don't usually go unnoticed. But one killer has been largely ignored for decades. Now, thanks to worries about bioterror, it is being taken more seriously. Peter Aldhous reports.
Nature (07 April 2005)
| Full Text |
Stem-cell research: After the gold rush
California's voters have authorized the spending of $3 billion over the next decade on stem-cell research. But will this bonanza bring threats as well as opportunities? Peter Aldhous weighs the hopes and fears.
Nature (07 April 2005)
| Full Text |
Drug safety special: The safety catch
The past year has seen a beleaguered Food and Drug Administration publicly denounced as unable to protect the US public. As the political pressure mounts, Meredith Wadman joins the agency's hunt for a remedy to its ills.
Nature (31 March 2005)
| Full Text |
Drug safety special: Chasing shadows
Why do current safety systems sometimes fail to notice that approved drugs are causing serious adverse effects? And can surveillance methods be improved?
Nature (31 March 2005)
| Full Text |
|
